deltatrials
Unknown PHASE4 NCT02666651

Regional Tolvaptan Registry

Sponsor: Cardiology Research UBC

Conditions Decompensated Heart Failure Hyponatremia
Interventions No intervention Tolvaptan
Updated 7 times since 2017 Last updated: Aug 8, 2018 Started: May 31, 2016 Primary completion: Jan 31, 2020 Completion: Jan 31, 2020

Listed as NCT02666651, this PHASE4 trial focuses on Decompensated Heart Failure and Hyponatremia and remains ongoing. Sponsored by Cardiology Research UBC, it has been updated 7 times since 2016, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Sep 2020 — Jan 2021 [monthly]

    Unknown Status PHASE4

    Status: Recruiting → Unknown Status

  5. Sep 2018 — Sep 2020 [monthly]

    Recruiting PHASE4

▶ Show 2 earlier versions

  1. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE4

  2. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

    First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cardiology Research UBC
Data source: Cardiology Research UBC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Vancouver, Canada